Etoray-MR Tablet is a combination medication containing Etoricoxib 60mg and Thiocolchicoside 4mg, formulated to provide effective relief from pain and inflammation associated with musculoskeletal conditions. Etoricoxib, a selective COX-2 inhibitor, works by reducing the production of prostaglandins responsible for inflammation and pain, making it particularly useful in managing osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. Thiocolchicoside, a muscle relaxant with anti-inflammatory properties, helps alleviate muscle spasms and stiffness, enhancing mobility and comfort. Together, these components offer a dual-action approach by addressing both inflammation and muscle tension, thereby improving patient outcomes in conditions involving painful muscle spasms and inflammatory joint disorders. Etoray-MR is typically prescribed for short-term use under medical supervision, and patients should adhere to the recommended dosage to minimize potential side effects such as gastrointestinal discomfort, dizziness, or allergic reactions. It is contraindicated in individuals with hypersensitivity to its ingredients, active peptic ulcers, or severe hepatic or renal impairment. Before starting Etoray-MR, patients should inform their healthcare provider about any existing medical conditions or concurrent medications to avoid adverse interactions. This combination tablet is intended to enhance quality of life by effectively managing pain and muscle-related symptoms.